Emerging market (EM) assets are in the doghouse, hit hard by concerns over slowing growth, rising current account deficits, sliding currencies and the potential impact of a tapering in America's Quantitative Easing (QE) programme. While volatility is likely to continue near-term, the negative headlines leave valuations at compelling levels. Patient investors, mindful of overwhelming demographic tr